Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 1
2018 1
2019 1
2021 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
Janoschka C, Lindner M, Koppers N, Starost L, Liebmann M, Eschborn M, Schneider-Hohendorf T, Windener F, Schafflick D, Fleck AK, Koch K, Deffner M, Schwarze AS, Schulte-Mecklenbeck A, Metz I, Meuth SG, Gross CC, Meyer Zu Hörste G, Schwab N, Kuhlmann T, Wiendl H, Stoll M, Klotz L. Janoschka C, et al. Among authors: eschborn m. Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2209944120. doi: 10.1073/pnas.2209944120. Epub 2022 Dec 27. Proc Natl Acad Sci U S A. 2023. PMID: 36574650 Free PMC article.
CNS Pericytes Modulate Local T Cell Infiltration in EAE.
Koch K, Lindner M, Fleck AK, Liebmann M, Eschborn M, Zondler L, Diéguez-Hurtado R, Adams RH, Meyer Zu Hörste G, Zarbock A, Kuhlmann T, Wiendl H, Klotz L. Koch K, et al. Among authors: eschborn m. Int J Mol Sci. 2022 Oct 28;23(21):13081. doi: 10.3390/ijms232113081. Int J Mol Sci. 2022. PMID: 36361868 Free PMC article.
Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial.
Engel S, Klotz L, Wirth T, Fleck AK, Pickert G, Eschborn M, Kreuzburg S, Curella V, Bittner S, Zipp F, Schuppan D, Luessi F. Engel S, et al. Among authors: eschborn m. Ther Adv Neurol Disord. 2023 Jun 25;16:17562864231170928. doi: 10.1177/17562864231170928. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37384112 Free PMC article.
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
Teschner VE, Fleck AK, Walter C, Schwarze AS, Eschborn M, Wirth T, Steinberg OV, Schulte-Mecklenbeck A, Lu IN, Herrera-Rivero M, Janoschka C, Lünemann JD, Schwab N, Meyer Zu Hörste G, Varghese J, Gross CC, Pul R, Kleinschnitz C, Mader S, Meinl E, Stoll M, Wiendl H, Klotz L. Teschner VE, et al. Among authors: eschborn m. Ther Adv Neurol Disord. 2023 Dec 9;16:17562864231211077. doi: 10.1177/17562864231211077. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38084102 Free PMC article.
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis.
Eschborn M, Pawlitzki M, Wirth T, Nelke C, Pfeuffer S, Schulte-Mecklenbeck A, Lohmann L, Rolfes L, Pape K, Eveslage M, Bittner S, Gross CC, Ruck T, Wiendl H, Meuth SG, Klotz L. Eschborn M, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 19;8(6):e1094. doi: 10.1212/NXI.0000000000001094. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34667129 Free PMC article.
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity.
Fleck AK, Hucke S, Teipel F, Eschborn M, Janoschka C, Liebmann M, Wami H, Korn L, Pickert G, Hartwig M, Wirth T, Herold M, Koch K, Falk-Paulsen M, Dobrindt U, Kovac S, Gross CC, Rosenstiel P, Trautmann M, Wiendl H, Schuppan D, Kuhlmann T, Klotz L. Fleck AK, et al. Among authors: eschborn m. Brain. 2021 May 7;144(4):1152-1166. doi: 10.1093/brain/awab040. Brain. 2021. PMID: 33899089 Free PMC article. Clinical Trial.
Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.
Granado D, Müller D, Krausel V, Kruzel-Davila E, Schuberth C, Eschborn M, Wedlich-Söldner R, Skorecki K, Pavenstädt H, Michgehl U, Weide T. Granado D, et al. Among authors: eschborn m. J Am Soc Nephrol. 2017 Nov;28(11):3227-3238. doi: 10.1681/ASN.2016111220. Epub 2017 Jul 10. J Am Soc Nephrol. 2017. PMID: 28696248 Free PMC article.
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Klotz L, Eschborn M, Lindner M, Liebmann M, Herold M, Janoschka C, Torres Garrido B, Schulte-Mecklenbeck A, Gross CC, Breuer J, Hundehege P, Posevitz V, Pignolet B, Nebel G, Glander S, Freise N, Austermann J, Wirth T, Campbell GR, Schneider-Hohendorf T, Eveslage M, Brassat D, Schwab N, Loser K, Roth J, Busch KB, Stoll M, Mahad DJ, Meuth SG, Turner T, Bar-Or A, Wiendl H. Klotz L, et al. Among authors: eschborn m. Sci Transl Med. 2019 May 1;11(490):eaao5563. doi: 10.1126/scitranslmed.aao5563. Sci Transl Med. 2019. PMID: 31043571 Clinical Trial.
Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity.
Liebmann M, Hucke S, Koch K, Eschborn M, Ghelman J, Chasan AI, Glander S, Schädlich M, Kuhlencord M, Daber NM, Eveslage M, Beyer M, Dietrich M, Albrecht P, Stoll M, Busch KB, Wiendl H, Roth J, Kuhlmann T, Klotz L. Liebmann M, et al. Among authors: eschborn m. Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E8017-E8026. doi: 10.1073/pnas.1721049115. Epub 2018 Aug 2. Proc Natl Acad Sci U S A. 2018. PMID: 30072431 Free PMC article.
12 results